Search
for
Sort by
Research 601–630 of 1000+
- THE PATHOGENESIS OF ALOPECIA AREATA
- Treatment of Alopecia Areata With Tofacitinib
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis
- Factors Associated with Severity of Alopecia Areata
- The role of lymphocytes in the development and treatment of alopecia areata
- Acute Diffuse and Total Alopecia of the Female Scalp
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Alopecia Areata
- TREATMENT OF ALOPECIA AREATA
- Histopathology of alopecia areata, acute and chronic: Why is it important to the clinician?
- Tofacitinib therapy for children with severe alopecia areata
- Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Trichoscopic findings in alopecia areata and their relation to disease activity, severity and clinical subtype in Turkish patients
- Treatment of severe alopecia areata with baricitinib
- Quality of life in patients with alopecia areata: a hospital‐based cross‐sectional study
- Systematic review of platelet‐rich plasma in treating alopecia: Focusing on efficacy, safety, and therapeutic durability
- Alopecia Areata
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Comparison of quality of life in patients with androgenetic alopecia and alopecia areata
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Integrative analysis of rare copy number variants and gene expression data in alopecia areata implicates an aetiological role for autophagy
- Psychosomatic aspects of alopecia areata
- Differential proteomics of lesional vs. non-lesional biopsies revealed non-immune mechanisms of alopecia areata
- Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study
- Low-Dose Systemic Methotrexate Therapy for Recalcitrant Alopecia Areata
- Alopecia Areata
- Preferential Recognition of Hydroxyl Radical-Modified Superoxide Dismutase by Circulating Autoantibodies in Patients with Alopecia Areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?